Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for myopic macular degeneration has been reported in the published literature.
1 clinical trial registered, 1 recruiting. Interventions under study include procedural interventions. Pipeline includes 1 NA. Research is primarily industry-sponsored.
127 publications have been identified in PubMed for myopic macular degeneration. Research spans Epidemiology / Natural History (35%), Review / Meta-Analysis (20%), and Basic Science / Preclinical (15%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 45 | 35% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 3:05 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries | 25 | 20% |
Laboratory research | 19 | 15% |
Testing and diagnosis research | 17 | 13% |
Clinical study results | 10 | 8% |
Patient case studies | 5 | 4% |
New treatment approaches | 5 | 4% |
Other research | 1 | 1% |
Martinez-Perez C (2026). [PMID: 41584097](https://pubmed.ncbi.nlm.nih.gov/41584097/). *Ophthalmol Sci*. [Review / Meta-Analysis]
Carlà MM (2026). [PMID: 41535097](https://pubmed.ncbi.nlm.nih.gov/41535097/). *Br J Ophthalmol*. [Diagnostic / Biomarker]
Agius D (2026). [PMID: 41890681](https://pubmed.ncbi.nlm.nih.gov/41890681/). *Clin Optom (Auckl)*. [Epidemiology / Natural History]
Moukadem O (2026). [PMID: 41218192](https://pubmed.ncbi.nlm.nih.gov/41218192/). *Retina*. [Epidemiology / Natural History]
Lee YH (2026). [PMID: 41633654](https://pubmed.ncbi.nlm.nih.gov/41633654/). *Korean J Ophthalmol*. [Review / Meta-Analysis]
Lee JH (2026). [PMID: 41986091](https://pubmed.ncbi.nlm.nih.gov/41986091/). *Br J Ophthalmol*. [Clinical Trial Publication]
Wang YX (2026). [PMID: 42168916](https://pubmed.ncbi.nlm.nih.gov/42168916/). *BMC Ophthalmol*. [Basic Science / Preclinical]
Mesfin Y (2026). [PMID: 41636834](https://pubmed.ncbi.nlm.nih.gov/41636834/). *Graefes Arch Clin Exp Ophthalmol*. [Review / Meta-Analysis]
Jonas JB (2026). [PMID: 42134650](https://pubmed.ncbi.nlm.nih.gov/42134650/). *Asia Pac J Ophthalmol (Phila)*. [Review / Meta-Analysis]
Tse DY (2026). [PMID: 41973601](https://pubmed.ncbi.nlm.nih.gov/41973601/). *JMIR Res Protoc*. [Clinical Trial Publication]